SEARCH

SEARCH BY CITATION

References

  • 1
    Andersen AN, Yue Z, Meng FJ, Petersen K. Low implantation rate after in-vitro fertilization in patients with hydrosalpinges diagnosed by ultrasonography. Hum Reprod 1994;9:19358.
  • 2
    Blazar AS, Hogan JW, Seifer DB, Frishman GN, Wheeler CA, Haning RV. The impact of hydrosalpinx on successful pregnancy in tubal factor infertility treated by in vitro fertilization. Fertil Steril 1997;67:51720.
  • 3
    Katz E, Akman MA, Damewood MD, García JE. Deleterious effect of the presence of hydrosalpinx on implantation and pregnancy rates with in vitro fertilization. Fertil Steril 1996;66:1225.
  • 4
    Murray DL, Sagoskin AW, Widra EA, Levy MJ. The adverse effect of hydrosalpinges on in vitro fertilization pregnancy rates and the benefit of surgical correction. Fertil Steril 1998;69:415.
  • 5
    Strandell A, Waldenström U, Nilsson L, Hamberger L. Hydrosalpinx reduces in-vitro fertilization/embryo transfer pregnancy rates. Hum Reprod 1994;9:8613.
  • 6
    Camus E, Poncelet C, Goffinet F, Wainer B, Merlet F, Nisand I, et al. Pregnancy rates after in-vitro fertilization in cases of tubal infertility with and without hydrosalpinx: a meta-analysis of published comparative studies. Hum Reprod 1999;14:12439.
  • 7
    Zeyneloglu HB, Arici A, Olive DL. Adverse effects of hydrosalpinx on pregnancy rates after in vitro fertilization-embryo transfer. Fertil Steril 1998;70:4929.
  • 8
    Johnson N, van Voorst S, Sowter MC, Strandell A, Mol BW. Surgical treatment for tubal disease in women due to undergo in vitro fertilisation. Cochrane Database Syst Rev 2010;CD002125.
  • 9
    ASRM. Practice Committee of American Society for Reproductive Medicine in collaboration with Society of Reproductive Surgeons. Salpingectomy for hydrosalpinx prior to in vitro fertilization. Fertil Steril 2008;90:S668.
  • 10
    Legendre G, Gallot V, Levaillant JM, Capmas P, Fernandez H. [Adiana(®) hysteroscopic tubal occlusion device for the treatment of hydrosalpinx prior to in vitro fertilization: a case report]. J Gynecol Obstet Biol Reprod (Paris) 2013;42:4014.
  • 11
    Smith RD. Contemporary hysteroscopic methods for female sterilization. Int J Gynaecol Obstet 2010;108:7984.
  • 12
    Hurskainen R, Hovi SL, Gissler M, Grahn R, Kukkonen-Harjula K, Nord-Saari M, et al. Hysteroscopic tubal sterilization: a systematic review of the Essure system. Fertil Steril 2010;94:169.
  • 13
    Rosenfield RB, Stones RE, Coates A, Matteri RK, Hesla JS. Proximal occlusion of hydrosalpinx by hysteroscopic placement of microinsert before in vitro fertilization-embryo transfer. Fertil Steril 2005;83:154750.
  • 14
    Agresti A, Coull BA. Approximate is Better than “exact” for interval estimation of binomial proportions. Am Stat 1998;52:11926.
  • 15
    Higgins JP, Altman DG, Gøtzsche PC, Jüni P, Moher D, Oxman AD, et al. Cochrane Bias Methods Group; Cochrane Statistical Methods Group. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ 2011;343:d5928.
  • 16
    Wells GA, Shea B, O'Connell D, Peterson J, Welch V, Losos M, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. [www.ohri.ca/programs/clinical_epidemiology/oxford.asp]. Accessed 14 August 2013.
  • 17
    Hesla JS, Rosenfield RB, Coates A, Stones RE, Matteri RK. Proximal occlusion of hydrosalpinx by hysteroscopic placement of microinsert before in vitro fertilization-embryo transfer. Fertil Steril 2004;82:S108.
  • 18
    Galen DI, Khan NM. Use of essure micro-insert for treatment of hydrosalpinx prior to in vitro fertilization: a multicenter IDE/IRB off-label study. Fertil Steril 2010;94:S55.
  • 19
    Dreyer K, Mijatovic V, Emanuel MH, Schats R, Hompes P. Essure hydrosalpinx occlusion prior to IVF-ET/frozen embryo transfer in patients with contradiction to laparoscopy. Fertil Steril 2011;96:S31.
  • 20
    Mijatovic V, Dreyer K, Emanuel MH, Schats R, Hompes P. Essure hydrosalpinx occlusion prior to IVF-ET/frozen embryo transfer in patients with a contraindication for laparoscopy. J Minim Invasive Gynecol 2011;18:S6.
  • 21
    Rabanal A, Prieto B, Matorras R, Urquijo E, Diez S, Brouard I, et al. Hysteroscopic treatment of hydrosalpinx prior to in vitro fertilization – embryo transfer (ivF-et). Hum Reprod 2010;25:i645.
  • 22
    Panel P, Grosdemouge I, Houllier M, Renouvel F, Friederich L, Le Tohic A. Bipolar hysteroscopic procedures and placement of Essure microinserts for tubal sterilization: a case control study. Fertil Steril 2011;95:24225.
  • 23
    Fernandez H, Panel P, Blein C, Lamarsalle L. Efficacy of tubal sterilization: reported pregnancies after tubal ligation and essure hysteroscopic sterilization—French enquiry 2006–2010. J Minim Invasive Gynecol 2012;19:S1920.
  • 24
    Chapa HO, Antonetti AG, Bakker K. Essure sterilization in patients with history of pelvic inflammatory disease and hydrosalpinges: an analysis on feasibility and clinical outcomes. J Gynecol Surg 2012;28:3436.
  • 25
    Aboulghar MA. Hydrosalpinx and the outcome of IVF: current status. Expert Rev Obstet Gynecol 2008;3:5239.
  • 26
    Sonigo C, Collinet P, Rubod C, Catteau-Jonard S. [Current position of Essure® micro-insert in the management of hydrolsalpinges before in vitro fertilization]. Gynecol Obstet Fertil 2013;41:1338.
  • 27
    Mijatovic V, Veersema S, Emanuel MH, Schats R, Hompes PG. Essure hysteroscopic tubal occlusion device for the treatment of hydrosalpinx prior to in vitro fertilization-embryo transfer in patients with a contraindication for laparoscopy. Fertil Steril 2010;93:133842.
  • 28
    Dreyer K, Mijatovic V, Emanuel MH, Hompes PGA. Hysterosalpingo-foam sonography (HYFOSY), a new technique to confirm proximal tubal occlusion after treatment of a hydrosalpinx by an Essure device prior to in vitro fertilization (IVF). Fertil Steril 2012;98:S224.
  • 29
    Mijatovic V. Prospective randomized trial to evaluate and to compare the impact of hysteroscopic and laparoscopic salpingectomy on IVF-ET outcomes of patients with hydrosalpinx. - Dutch Essure® versus Salpingectomy for Hydrosalpinx. [http://apps.who.int/trialsearch/Trial.aspx?TrialID=NTR2073]. Accessed 14 August 2013.
  • 30
    Hitkari JA, Singh SS, Shapiro HM, Leyland N. Essure treatment of hydrosalpinges. Fertil Steril 2007;88:16636.
  • 31
    Galen DI. Utilization of the Essure® micro-insert for the treatment of hydrosalpinx prior to in vitro fertilization. Fertil Steril 2007;88:S16.
  • 32
    Gil N, Arias RA. Hysteroscopic contraception is an option to IVF patients with hydrosalpinges. Gynecol Surg 2009;6:S108.
  • 33
    Omurtag K, Pauli S, Session D. Spontaneous intrauterine pregnancy after unilateral placement of tubal occlusive microinsert. Fertil Steril 2009;92:393. e15–392. e17.
  • 34
    Nichols JE, West JR. Success of Essure© micro-inserts in the treatment of hydrosalpinx prior to in vitro fertilization (IVF)/frozen embryo transfer (FET) and pregnancy outcomes. Fertil Steril 2010;94:S245.
  • 35
    Galen DI, Khan N, Richter KS. Essure multicenter off-label treatment for hydrosalpinx before in vitro fertilization. J Minim Invasive Gynecol 2011;18:33842.
  • 36
    Mijatovic V, Dreyer K, Emanuel MH, Schats R, Hompes PG. Essure(®) hydrosalpinx occlusion prior to IVF-ET as an alternative to laparoscopic salpingectomy. Eur J Obstet Gynecol Reprod Biol 2012;161:425.
  • 37
    Thébault N, Broux PL, Moy L, Vialard J. Utilization of Essure(®) micro-insert for hydrosalpynx occlusion in infertile women. J Gynecol Obstet Biol Reprod (Paris) 2012;41:14550.
  • 38
    Inocêncio G, Coutinho L, Maciel R, Barreiro M. Pregnancy after hydrosalpinx treatment with Essure. BMJ Case Rep 2013. doi: 10.1136/bcr-2013-009018.
  • 39
    Matorras R, Rabanal A, Prieto B, Diez S, Brouard I, Mendoza R, et al. Hysteroscopic hydrosalpinx occlusion with Essure device in IVF patients when salpingectomy or laparoscopy is contraindicated. Eur J Obstet Gynecol Reprod Biol 2013;169:549.
  • 40
    Cooper JM, Carignan CS, Cher D, Kerin JF. Selective Tubal Occlusion Procedure 2000 Investigators Group. Microinsert nonincisional hysteroscopic sterilization. Obstet Gynecol 2003;102:5967.
  • 41
    Kerin JF, Cooper JM, Price T, Herendael BJ, Cayuela-Font E, Cher D, et al. Hysteroscopic sterilization using a micro-insert device: results of a multicentre Phase II study. Hum Reprod 2003;18:122330.
  • 42
    Miño M, Arjona JE, Cordón J, Pelegrin B, Povedano B, Chacon E. Success rate and patient satisfaction with the Essure sterilisation in an outpatient setting: a prospective study of 857 women. BJOG 2007;114:7636.
  • 43
    Kerin JF, Munday DN, Ritossa MG, Pesce A, Rosen D. Essure hysteroscopic sterilization: results based on utilizing a new coil catheter delivery system. J Am Assoc Gynecol Laparosc 2004;11:38893.
  • 44
    Hopkins MR, Creedon DJ, Wagie AE, Williams AR, Famuyide AO. Retrospective cost analysis comparing Essure hysteroscopic sterilization and laparoscopic bilateral tubal coagulation. J Minim Invasive Gynecol 2007;14:97102.
  • 45
    Levie MD, Chudnoff SG. Office hysteroscopic sterilization compared with laparoscopic sterilization: a critical cost analysis. J Minim Invasive Gynecol 2005;12:31822.
  • 46
    HFEA (Human Fertilisation and Embryology Authority). Fertility treatment in 2010 – trends and figures. 2011 [www.hfea.gov.uk/docs/2011-11-16_-_Annual_Register_Figures_Report_final.pdf]. Accessed 24 January 2012.
  • 47
    Hammadieh N, Olufowobi O, Afnan M, Sharif K. Factors affecting the outcome of in vitro fertilisation treatment. In: Studd J, editor. Progress in Obstetrics and Gynaecology Volume 16. Edinburgh, UK: Elsevier Health Sciences; 2005. pp. 25976.
  • 48
    Beyler SA, James KP, Fritz MA, Meyer WR. Hydrosalpingeal fluid inhibits in-vitro embryonic development in a murine model. Hum Reprod 1997;12:27248.
  • 49
    Meyer WR, Lessey BA, Castelbaum AJ. Hydrosalpinx and altered uterine receptivity. Fertil Steril 1997;68:9445.
  • 50
    Mukherjee T, Copperman AB, McCaffrey C, Cook CA, Bustillo M, Obasaju MF. Hydrosalpinx fluid has embryotoxic effects on murine embryogenesis: a case for prophylactic salpingectomy. Fertil Steril 1996;66:8513.
  • 51
    Ng EH, Chan CC, Tang OS, Ho PC. Comparison of endometrial and subendometrial blood flows among patients with and without hydrosalpinx shown on scanning during in vitro fertilization treatment. Fertil Steril 2006;85:3338.
  • 52
    Strandell A, Lindhard A. Hydrosalpinx and ART. Salpingectomy prior to IVF can be recommended to a well-defined subgroup of patients. Hum Reprod 2000;15:20724.
  • 53
    Strandell A. Treatment of hydrosalpinx in the patient undergoing assisted reproduction. Curr Opin Obstet Gynecol 2007;19:3605.
  • 54
    Kerin JF, Cattanach S. Successful pregnancy outcome with the use of in vitro fertilization after Essure hysteroscopic sterilization. Fertil Steril 2007;87:1212. e1–4.
  • 55
    Moses AW, Burgis JT, Bacon JL, Risinger J. Pregnancy after Essure placement: report of two cases. Fertil Steril 2008;89:724. e9–11.
  • 56
    Levy B, Levie MD, Childers ME. A summary of reported pregnancies after hysteroscopic sterilization. J Minim Invasive Gynecol 2007;14:2714.
  • 57
    Wever DJ, Veldhuizen AG, Sanders MM, Schakenraad JM, van Horn JR. Cytotoxic, allergic and genotoxic activity of a nickel-titanium alloy. Biomaterials 1997;18:111520.